MIR422A: MIR422A is a microRNA that has been identified and validated in various studies [PMC5878888]. It has been found to be associated with processes such as apoptosis/survival, migration/chemotaxis, adhesion, transendothelial migration, differentiation into osteoclasts, histamine biosynthesis, glucocorticoid sensitivity, regulation of oxidative stress, and protein folding [PMC5878888]. MIR422A has been shown to be significantly associated with MVC% and MVC [PMC5803610]. It is one of the nine statistically significant miRNAs found in a conditional logistic regression analysis [PMC4436811]. MIR422A has been reported to inhibit the translation of mRNA encoding CYP7A protein [PMC8147992]. It has also been implicated in cholestatic liver diseases [PMC8147992]. In addition, MIR422A is predicted to target various genes involved in ion channel regulation and muscle growth pathways [PMC7763385] [PMC8396502]. It has also been found to be negatively correlated with hTERT protein expression levels [PMC4431439] and positively correlated with lncR-D63785 and MEF2D expressions in DOX-resistant GC cells [PMC8381522] [PMC8396502]. Furthermore, MIR422A levels have been shown to be reduced in aUC compared to iUC patients [PMC6879552], while exhibiting diurnal oscillations in the mouse retina along with other microRNAs such as miR96 and miR124a[ PMC3092095].